EGFR and non-small cell lung carcinoma: Gefitinib is a tyrosine kinase inhibitor known for targeting the epidermal growth factor receptor (EGFR) and is used in the treatment of non-small-cell lung cancer and other cancers of epithelial origin.8 The drug is well tolerated, with rash and diarrhea being the only dose-limiting toxicities.